Search research articles
Contact Us
Filters
Showing results (201-210 of 218) with videos related to
Page
of 22
Sort By:
BJU International
|
December 10, 2024
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function
Eiftu S Haile, Zaeem Lone, David Shin, et al.
Clinical Genitourinary Cancer
|
March 20, 2018
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial Carcinoma
Hamid Emamekhoo, Puneet Dhillon, Dharmesh Gopalakrishnan, et al.
BJU International
|
April 5, 2023
Functional recovery after partial nephrectomy: next generation analysis
Carlos Munoz-Lopez, Kieran Lewis, Worapat Attawettayanon, et al.
Urologic Oncology
|
May 10, 2024
Parenchymal obliteration by renal masses: Functional and oncologic implications
Akira Kazama, Carlos Munoz-Lopez, Worapat Attawettayanon, et al.
BJU International
|
June 17, 2024
Body morphometry may predict parastomal hernia following radical cystectomy with ileal conduit
Zaeem Lone, David Shin, Amy Nowacki, et al.
Urologic Oncology
|
December 23, 2023
Functional recovery after partial nephrectomy in a solitary kidney
Worapat Attawettayanon, Yosuke Yasuda, Jj H Zhang, et al.
European Urology Open Science
|
August 7, 2023
Selective Use of Neoadjuvant Targeted Therapy Is Associated with Greater Achievement of Partial Nephrectomy for High-complexity Renal Masses in a Solitary Kidney
Worapat Attawettayanon, Yosuke Yasuda, Jj H Zhang, et al.
European Urology Oncology
|
December 14, 2022
Comprehensive Management of Renal Masses in Solitary Kidneys
Yosuke Yasuda, Jj H Zhang, Worapat Attawettayanon, et al.
European Urology
|
February 19, 2013
Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysis
Francesco Greco, Riccardo Autorino, Koon H Rha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2018
Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target
Vadim S Koshkin, Jorge A Garcia, Jordan Reynolds, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 218) with videos related to
Sort By:
Page
of 22
BJU International
|
December 10, 2024
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function
Eiftu S Haile, Zaeem Lone, David Shin, et al.
Clinical Genitourinary Cancer
|
March 20, 2018
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial Carcinoma
Hamid Emamekhoo, Puneet Dhillon, Dharmesh Gopalakrishnan, et al.
BJU International
|
April 5, 2023
Functional recovery after partial nephrectomy: next generation analysis
Carlos Munoz-Lopez, Kieran Lewis, Worapat Attawettayanon, et al.
Urologic Oncology
|
May 10, 2024
Parenchymal obliteration by renal masses: Functional and oncologic implications
Akira Kazama, Carlos Munoz-Lopez, Worapat Attawettayanon, et al.
BJU International
|
June 17, 2024
Body morphometry may predict parastomal hernia following radical cystectomy with ileal conduit
Zaeem Lone, David Shin, Amy Nowacki, et al.
Urologic Oncology
|
December 23, 2023
Functional recovery after partial nephrectomy in a solitary kidney
Worapat Attawettayanon, Yosuke Yasuda, Jj H Zhang, et al.
European Urology Open Science
|
August 7, 2023
Selective Use of Neoadjuvant Targeted Therapy Is Associated with Greater Achievement of Partial Nephrectomy for High-complexity Renal Masses in a Solitary Kidney
Worapat Attawettayanon, Yosuke Yasuda, Jj H Zhang, et al.
European Urology Oncology
|
December 14, 2022
Comprehensive Management of Renal Masses in Solitary Kidneys
Yosuke Yasuda, Jj H Zhang, Worapat Attawettayanon, et al.
European Urology
|
February 19, 2013
Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysis
Francesco Greco, Riccardo Autorino, Koon H Rha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2018
Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target
Vadim S Koshkin, Jorge A Garcia, Jordan Reynolds, et al.
Page
of 22